J Breast Cancer.
2022 Jun;25(3):259. 10.4048/jbc.2022.25.e20.
Ipsilateral Lymphadenopathy, COVID-19 Vaccination and Breast Cancer
- Affiliations
-
- 1Private Academic Consultant, Bangkok, Thailand
- 2Department of Biological Science, Joseph Ayo Babalola University, Ikeji-Arakeji, Nigeria
- 3Department of Community Medicine, Dr DY Patil University, Pune, India
- KMID: 2530769
- DOI: http://doi.org/10.4048/jbc.2022.25.e20
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Management of Ipsilateral Axillary Lymphadenopathy Detected on Breast Ultrasound after COVID-19 Vaccination
- Ipsilateral Lymphadenopathy After COVID-19 Vaccination in Patients With Newly Diagnosed Breast Cancer
- Precautions for breast ultrasound examination following COVID-19 vaccination
- Ipsilateral Malignant Axillary Lymphadenopathy and Contralateral Reactive Lymph Nodes in a COVID-19 Vaccine Recipient With Breast Cancer
- COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT
